Combination therapy in benign prostatic hyperplasia (BPH);Les traitements combinés dans l'hypertrophie bénigne de la prostate (HBP)

Annales d'Urologie

Volumn 38, Issue SUPPL. 2, 2004, Pages

  Desgrandchamps, F ^a  

^a SAINT LOUIS HOSPITAL   (France)

Author keywords

Alphabloquants; Antimuscariniques; Benign prostatichyperplasia (BPH); Hypertrophie benigne de ta prostate (HBP); Inhibiteurs de la 5 r ductase; Lower urinary tract symptoms (LUTS); Muttitherapie; Troubles urinaires du bas appareil (TUBA)

Indexed keywords

ALFUZOSIN; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; DOXAZOSIN; FINASTERIDE; MUSCARINIC RECEPTOR BLOCKING AGENT; PROSTATE SPECIFIC ANTIGEN; SABAL EXTRACT; SILDENAFIL; STEROID 5ALPHA REDUCTASE INHIBITOR; TADALAFIL; TAMSULOSIN; TERAZOSIN; VARDENAFIL;

ASTHENIA; BLADDER IRRITATION; BLADDER NECK; DETRUSOR MUSCLE; DIZZINESS; DRUG EFFICACY; DYSPNEA; EJACULATION DISORDER; ERECTILE DYSFUNCTION; HUMAN; LIBIDO DISORDER; MUSCLE RELAXATION; ORGAN SIZE; ORTHOSTATIC HYPOTENSION; PATHOPHYSIOLOGY; PERIPHERAL EDEMA; PROSTATE; PROSTATE DISEASE; PROSTATE HYPERTROPHY; REVIEW; SMOOTH MUSCLE FIBER; SOMNOLENCE; SYNCOPE; URINARY TRACT OBSTRUCTION;

EID: 13244254011     PISSN: 00034401     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4401(04)80003-2     Document Type: Article

References (13)

1. Brookes S.T., Donovan J.L., Peters T.J., Abrams P., and Neal D.E. Sexual dysfunction in men after treatment for Lower urinary tract symptoms: evidence from randomised controlled trial BMJ 4 2002 1059 1061
2. De Rose A.F., Giglio M., Gallo F., and Carmignani G. Evaluation of the association between benign prostatic hyperplasia and sexual disorders Arch Ital Urol Androl 73 2001 173 176
3. Debruyne F.M., Jardin A., Colloi D., Resel L., Witjes W.P., and Delauche-Cavalier M.C. European ALFIN study group Eur Urol 34 1998 169 175
4. Glemain P., Coulange C., Billebaud T., Gattegno B., Muszynski R., and Loeb G. Groupe de l'essai OCOS. Tamsulosin with or without Serenoa repens in benign prostatic hyperplasia: the OCOS trial Prog Urol 12 2002 395 403
5. Lepor H., Williford W.O., Barry M.J., Brawer M.K., Dixon C.M., and Gormley G. The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. Veterans Affairs Coo perative Studies Benign ProstaticHyperplasia Study Group N Engl J Med 22 1996 533 539
6. Lepor H., Williford W.O., Barry M.J., Haakenson C., and Jones K. The impact of medical therapy on bother due to symptoms, quality of life and global outcome, and factors predicting response. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group J Urol 160 1998 1358 1367
7. Kirby R.S., Roehrborn C., Boyle P., Bartsch G., Jardin A., and Cary M.M. Prospective European Doxazosin and Combination Therapy Study Investigators. Efficacy and tolerability of doxazosin and finasteride, atone or incombination, in treatment of symptomatic benign prostatic hyperplasia: the Prospective European Doxazosin and Combination Therapy (PREDICT) trial Urology 61 2003 119 126
8. McConnell J.D., Roehrborn C.G., Bautista O.M., Andriole G.L. Jr, Dixon C.M., and Kusek J.W. The long term effect of doxazosin, finasteride and combination therapy on the clinical progression of begnin prostatic hyperplasia N Engl J Med 349 2003 2387 2398
9. Barkin J., GuimarÃes M., Jacobi G., Pushkar D., Taylor S., Van Vierssen Trip O.B. SMART-1 Investigator group Alpha-blocker therapy can be withdrawn in the majority of men following initial combination therapy with the dual 5-α-reductase inhibitordutasteride Eur Urol 44 2003 461 466
10. Rosen R., Altwein J., Boyle P., Kirby R.S., Lukacs B., and Meuleman E. Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7) Eur Urol 44 2003 637 649
11. Van Moorselaar R., Emberton M., Harving N., Matzkin H., Hartung H., and Alcaraz A. Alfuzosin 10 mg once a day improves sexual function in men with LUTS and concomittant sexual dysfunction sexual dysfunction Eur Urol 2 2003 285
12. De Rose A.F., Carmignani G., Corbu C., Giglio M., Traverso P., and Naselli A. Observational multicentric trial performed with diagnosed benign prostatic hyperplsia Urol Intern 68 2002 95 98
13. De Rose A.F., Giglio M., Traverso P., Lantieri P., and Carmignani G. Combined oral therapy with sitdenafit and doxazosin for the treatment of non-organic erectile dysfunction refractory to sildenafil monotherapy Int J Impot Res 14 2002 50 53